Statement from FDA for Devices and Radiological Health, on FDA’s updates to Medical Device Safety A
date:Nov 21, 2018
act on medical device safety signals will rest in part on our ability to fully leverage NEST as an active surveillance and evaluation system that complements the approaches currently in use by more quickly detecting emerging safety signals through active surveillance, supporting timely evaluation of these signals to determine if they represent a real risk to patients, and ensuring timely responses to new and increased risks.

Weve certainly made strides: FDA provided the seed funding that helped
17/23 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/11 06:05